Supreme Court lifts ban on sale of Saridon and two other drugs
New Delhi, Sept 17 (IBNS): Days after the Centre's ban on 328 combinationdrugs, the Supreme Court on Monday allowed the sale of Saridon and two other drugs for now, media reports said.
The top court passed the order after a petition against the ban was filed by the drug makers.
Around 6,000 drug brands including Saridon (painkiller), Panderm (skin cream), Lupidiclox (antibiotic), Corex (cough syrup) were expected to be affected by this ban.
In December 2017, the Supreme Court asked Drugs Technical Advisory Board (DTAB) to intervene in the matter.
The DTAB eventually said there was no therapeutic evidence that the ingredients in about 328 of these FDCs cause any harm to people.
The All India Drug Action Network sought the banning of the drugs which were not part of the DTAB report, as these itself accounted for about Rs 2,500 crore of the pharmaceutical market.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
